Medicare Part D was BrightSpring Health Services’s largest product and service line in fiscal 2025, bringing in $4.10B of $12.91B (32%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Medicare Part D | — | $2.03B | $3.20B | $4.10B |
| Medicare D | $1.48B | — | — | — |
| Commercial Insurance | $1.47B | $1.81B | $2.53B | $3.30B |
| Medicare Part C | — | $1.45B | $1.67B | $2.41B |
| Medicare C | $1.25B | — | — | — |
| Medicaid | $1.77B | $979.10M | $1.17B | $1.50B |
| Medicare Part A | — | $958.60M | $999.60M | $1.09B |
| Medicare A | $938.10M | — | — | — |
| Private & Other | $474.40M | $378.00M | $415.10M | $424.10M |
| Department Of Labor | $273.40M | — | — | — |
| Medicare Part B | — | $82.80M | $95.90M | $82.80M |
| Medicare B | $57.50M | — | — | — |
| Total | $7.72B | $7.69B | $10.07B | $12.91B |
BrightSpring Health Services brought in $12.91B from its seven product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 28.2% from $10.07B in fiscal 2024. Medicare Part D was the largest at $4.10B (31.7%), ahead of Commercial Insurance at $3.30B (25.6%) and Medicare Part C at $2.41B (18.7%). The other four lines brought in $3.10B combined.
Compared with fiscal 2024, Medicare Part C grew fastest, up 44.9% to $2.41B. Every line above 2% of revenue grew.
BrightSpring Health Services began breaking out Medicare Part D in fiscal 2023, Medicare Part C in fiscal 2023, Medicare Part A in fiscal 2023 and Medicare Part B in fiscal 2023. BrightSpring Health Services stopped reporting Medicare D ($1.48B in fiscal 2022), Medicare C ($1.25B in fiscal 2022), Medicare A ($938.10M in fiscal 2022) and two others as separate lines.
Pharmacy Solutions was BrightSpring Health Services’s largest segment in fiscal 2025, bringing in $11.45B of $12.91B (89%).
| Segment | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Pharmacy Solutions | $5.26B | $6.52B | $8.75B | $11.45B |
| Provider Services | $2.18B | $1.17B | $1.32B | $1.46B |
| Other | $274.70M | — | — | — |
| Total | $7.72B | $7.69B | $10.07B | $12.91B |
BrightSpring Health Services brought in $12.91B from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 28.2% from $10.07B in fiscal 2024. Pharmacy Solutions was the largest at $11.45B (88.7%), ahead of Provider Services at $1.46B (11.3%).
Compared with fiscal 2024, Pharmacy Solutions grew 30.7% to $11.45B and Provider Services grew 11.1% to $1.46B.
BrightSpring Health Services stopped reporting Other as a separate segment after fiscal 2022, when it brought in $274.70M.
BrightSpring Health Services (BTSGU) reports its revenue by product and service and by segment. In fiscal 2025, Medicare Part D was its largest product and service line, bringing in $4.10B (31.7% of the total), followed by Commercial Insurance at $3.30B (25.6%).
Medicare Part D was BrightSpring Health Services' largest product and service line in fiscal 2025, bringing in $4.10B, or 31.7% of the $12.91B total across its seven product and service lines.
Pharmacy Solutions was BrightSpring Health Services' largest segment in fiscal 2025, bringing in $11.45B, or 88.7% of the $12.91B total across its two segments.
Among BrightSpring Health Services' product and service lines that make up at least 2% of revenue, Medicare Part C grew fastest in fiscal 2025, up 44.9% from $1.67B to $2.41B.
Every figure comes from BrightSpring Health Services' annual financial filings, as reported. Each line keeps the name BrightSpring Health Services gives it, and years follow its fiscal calendar.
BrightSpring Health Services' revenue by product and service goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.